First-In-Class Nasacort OTC Also Originates ‘Children’s’ Label
This article was originally published in The Tan Sheet
Executive Summary
Sanofi introduces Children’s Nasacort Allergy 24HR in the same formulation and dosage as the original OTC switch, but with “children’s” added to the package after approval by FDA. The firm promotes the product as the “first and only” 24-hour multi-symptom nasal allergy spray available OTC for children ages 2 and up.
You may also be interested in...
Children's Flonase Is Latest Play For Nasal Allergy Spray Market Share
Children's Flonase, like Children's Nasacort, is the same formulation and is indicated for the same overall age groups as the original product, but its labeling includes additional detail for use by children.
Children's Flonase Is Latest Play For Nasal Allergy Spray Market Share
Children's Flonase, like Children's Nasacort, is the same formulation and is indicated for the same overall age groups as the original product, but its labeling includes additional detail for use by children.
Icy Hot SmartRelief Latest TENS Target Is Back Pain
Chattem rolls out Icy Hot SmartRelief Back & Hip device for drug-free pain relief for sore or aching muscles, chronic pain and arthritis, the Sanofi subsidiary says. The Back & Hip and Knee & Shoulder products feature the same control unit but different electrode pads, with refills sold without a control unit.